GAE Cuts Knee Osteoarthritis Pain 57% in 194-Patient Study as Coverage Varies
Updated
Updated · health.yahoo.com · Jun 25
GAE Cuts Knee Osteoarthritis Pain 57% in 194-Patient Study as Coverage Varies
2 articles · Updated · health.yahoo.com · Jun 25
Summary
A 1- to 2-hour outpatient procedure called genicular artery embolization reduced median knee osteoarthritis pain 57% over a year after a single treatment in a 194-patient study.
GAE works by threading a small catheter through the wrist or groin and blocking blood flow to inflamed knee tissue, with most patients going home the same day and recovering in days.
Adults with moderate to severe chronic knee pain that persists after at least 3 months of physical therapy, medication or injections are the main candidates; grade 4 bone-on-bone arthritis usually is not.
Costs run about $4,000 to $10,000, and insurance coverage remains inconsistent because many insurers still view GAE as a relatively new osteoarthritis treatment.
Experts said patients can improve approval odds by documenting ongoing pain, trying conservative care first, providing imaging and physician notes, and appealing denials with added medical evidence.
With scientists now able to regrow cartilage, is a new pain-blocking procedure for arthritis already obsolete before it becomes mainstream?
A top society endorses a new knee procedure that a major trial found was no better than a placebo. What's the real story here?
Transforming Knee Osteoarthritis Care: The Rise of Genicular Artery Embolization and Its Impact on Patients and Health Systems
Overview
Genicular Artery Embolization (GAE) is a promising new treatment for knee osteoarthritis, especially for patients who have not improved with conservative therapies and are not ready for major surgery. GAE stands out because it does not require large incisions or hospital stays, allowing most people to return to normal activities within days. Clinical studies show that GAE can quickly reduce pain by up to 50% in the first week, with relief often lasting for years. These benefits, along with a low risk of side effects, make GAE an attractive option for improving quality of life in people with knee osteoarthritis.